These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18055488)

  • 21. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.
    Cordonnier C; Ribaud P; Herbrecht R; Milpied N; Valteau-Couanet D; Morgan C; Wade A;
    Clin Infect Dis; 2006 Apr; 42(7):955-63. PubMed ID: 16511759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
    Halliday C; Hoile R; Sorrell T; James G; Yadav S; Shaw P; Bleakley M; Bradstock K; Chen S
    Br J Haematol; 2006 Feb; 132(4):478-86. PubMed ID: 16412020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using the galactomannan antigen assay in the diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation.
    Tănase AD; Coliţă A; Mărculescu A; Berteanu C; Streinu Cercel A; Stoica M; Stoica A; Cernea D; Copotoiu S; Brînzaniuc K; Azamfirei L
    Rom J Morphol Embryol; 2012; 53(2):379-82. PubMed ID: 22732810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation.
    Mihu CN; King E; Yossepovitch O; Taur Y; Jakubowski A; Pamer E; Papanicolaou GA
    Transpl Infect Dis; 2008 Jun; 10(3):162-7. PubMed ID: 17662036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
    Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galactomannan antigenemia for the diagnosis of invasive aspergillosis in neutropenic patients with hematological disorders.
    Suankratay C; Kanitcharaskul P; Arunyingmongkol K
    J Med Assoc Thai; 2006 Nov; 89(11):1851-8. PubMed ID: 17205865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Platelia Aspergillus enzyme immunoassay for the diagnosis of invasive aspergillosis.
    Lai CC; Hsu HL; Lee LN; Hsueh PR
    J Microbiol Immunol Infect; 2007 Apr; 40(2):148-53. PubMed ID: 17446963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
    Pazos C; Pontón J; Del Palacio A
    J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination of real-time polymerase chain reaction assay and serum galactomannan in the diagnosis of invasive aspergillosis in patients with hematological malignancies and recipients of hematopoietic stem cell transplantation].
    Sun YQ; Ji Y; Xu LP; Liu DH; Liu KY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):375-8. PubMed ID: 20367932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.
    Post MJ; Lass-Floerl C; Gastl G; Nachbaur D
    Transpl Infect Dis; 2007 Sep; 9(3):189-95. PubMed ID: 17511828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The value of serum galactomannan antigen for detection of invasive aspergillosis in hematological patients].
    Xie LP; Liu T; Meng WT; Zhou J
    Zhonghua Nei Ke Za Zhi; 2006 Dec; 45(12):992-5. PubMed ID: 17326997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis.
    Millon L; Piarroux R; Deconinck E; Bulabois CE; Grenouillet F; Rohrlich P; Costa JM; Bretagne S
    J Clin Microbiol; 2005 Oct; 43(10):5097-101. PubMed ID: 16207969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High incidence of false-positive Aspergillus galactomannan test in multiple myeloma.
    Mori Y; Nagasaki Y; Kamezaki K; Takenaka K; Iwasaki H; Harada N; Miyamoto T; Abe Y; Shimono N; Akashi K; Teshima T
    Am J Hematol; 2010 Jun; 85(6):449-51. PubMed ID: 20513124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
    Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the galactomannan assay for the diagnosis of invasive aspergillosis in patients].
    Wen YT; Zhao BL; Lü PH; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):287-90. PubMed ID: 18846967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients.
    Maertens J; Van Eldere J; Verhaegen J; Verbeken E; Verschakelen J; Boogaerts M
    J Infect Dis; 2002 Nov; 186(9):1297-306. PubMed ID: 12402199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
    Aguado JM; Vázquez L; Fernández-Ruiz M; Villaescusa T; Ruiz-Camps I; Barba P; Silva JT; Batlle M; Solano C; Gallardo D; Heras I; Polo M; Varela R; Vallejo C; Olave T; López-Jiménez J; Rovira M; Parody R; Cuenca-Estrella M; ; ; ;
    Clin Infect Dis; 2015 Feb; 60(3):405-14. PubMed ID: 25336623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.
    White PL; Linton CJ; Perry MD; Johnson EM; Barnes RA
    Clin Infect Dis; 2006 Feb; 42(4):479-86. PubMed ID: 16421791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation.
    Kontoyiannis DP; Chamilos G; Lewis RE; Giralt S; Cortes J; Raad II; Manning JT; Han X
    Cancer; 2007 Sep; 110(6):1303-6. PubMed ID: 17614303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.